# Katapult Holdings, Inc.: financial statements, quarterly

KPLT · Nasdaq · CIK 1785424 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kplt.md) · [Financials](/companies/kplt/financials.md) · [Filings](/companies/kplt/filings.md) · [Insiders](/companies/kplt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kplt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [54.8](/filings/0001628280-24-045451.md) | [57.6 d](/filings/0001628280-25-015331.md) | [65.1](/filings/0001628280-25-026057.md) | [58.9](/filings/0001628280-25-040169.md) | [60.3](/filings/0001628280-25-051372.md) | [63.0 d](/filings/0001628280-26-016661.md) | [71.9](/filings/0001628280-26-032985.md) | [71.9](/filings/0001628280-26-052176.md) | [74.0](/filings/0001628280-25-051372.md) | [73.9 d](/filings/0001628280-26-016661.md) | [79.0](/filings/0001628280-26-032985.md) | [74.8](/filings/0001628280-26-052176.md) |
| Cost of revenue | $m | [43.3](/filings/0001628280-24-045451.md) | [48.7 d](/filings/0001628280-25-015331.md) | [48.6](/filings/0001628280-25-026057.md) | [48.9](/filings/0001628280-25-040169.md) | [48.4](/filings/0001628280-25-051372.md) | [55.6 d](/filings/0001628280-26-016661.md) | [57.6](/filings/0001628280-26-032985.md) | [60.7](/filings/0001628280-26-052176.md) | [59.5](/filings/0001628280-25-051372.md) | [62.4 d](/filings/0001628280-26-016661.md) | [60.8](/filings/0001628280-26-032985.md) | [63.3](/filings/0001628280-26-052176.md) |
| Gross profit | $m | [11.5](/filings/0001628280-24-045451.md) | [8.9 d](/filings/0001628280-25-015331.md) | [16.5](/filings/0001628280-25-026057.md) | [9.9](/filings/0001628280-25-040169.md) | [11.9](/filings/0001628280-25-051372.md) | [7.4 d](/filings/0001628280-26-016661.md) | [14.3](/filings/0001628280-26-032985.md) | [11.2](/filings/0001628280-26-052176.md) | [14.6](/filings/0001628280-25-051372.md) | [11.5 d](/filings/0001628280-26-016661.md) | [18.2](/filings/0001628280-26-032985.md) | [11.5](/filings/0001628280-26-052176.md) |
| Operating income | $m | [(0.4)](/filings/0001628280-24-045451.md) | [(10.6) d](/filings/0001628280-25-015331.md) | [3.8](/filings/0001628280-25-026057.md) | [(2.6)](/filings/0001628280-25-040169.md) | [(4.4)](/filings/0001628280-25-051372.md) | [(4.8) d](/filings/0001628280-26-016661.md) | [(0.5)](/filings/0001628280-26-032985.md) | [(1.4)](/filings/0001628280-26-052176.md) | [2.5](/filings/0001628280-25-051372.md) | [(1.0) d](/filings/0001628280-26-016661.md) | [4.3](/filings/0001628280-26-032985.md) | [(1.9)](/filings/0001628280-26-052176.md) |
| Interest expense | $m | [4.3](/filings/0001628280-24-017691.md) | [4.3 d](/filings/0001628280-24-017691.md) | [4.5](/filings/0001628280-24-023376.md) | [4.7](/filings/0001628280-25-040169.md) | [4.8](/filings/0001628280-25-051372.md) | [4.8 d](/filings/0001628280-26-016661.md) | [5.1](/filings/0001628280-26-032985.md) | [5.4](/filings/0001628280-26-052176.md) | [5.9](/filings/0001628280-25-051372.md) | [4.1 d](/filings/0001628280-26-016661.md) | [3.1](/filings/0001628280-26-032985.md) | [3.2](/filings/0001628280-26-052176.md) |
| Income tax | $m | [0.0](/filings/0001628280-24-045451.md) | [0.1 d](/filings/0001628280-25-015331.md) | [0.0](/filings/0001628280-25-026057.md) | [0.1](/filings/0001628280-25-040169.md) | [0.0](/filings/0001628280-25-051372.md) | [0.0 d](/filings/0001628280-26-016661.md) | [0.0](/filings/0001628280-26-032985.md) | [0.1](/filings/0001628280-26-052176.md) | [(0.1)](/filings/0001628280-25-051372.md) | [0.3 d](/filings/0001628280-26-016661.md) | [(0.0)](/filings/0001628280-26-032985.md) | [0.1](/filings/0001628280-26-052176.md) |
| Net income | $m | [(4.1)](/filings/0001628280-24-045451.md) | [(14.6) d](/filings/0001628280-25-015331.md) | [(0.6)](/filings/0001628280-25-026057.md) | [(6.9)](/filings/0001628280-25-040169.md) | [(8.9)](/filings/0001628280-25-051372.md) | [(9.6) d](/filings/0001628280-26-016661.md) | [(5.7)](/filings/0001628280-26-032985.md) | [(7.8)](/filings/0001628280-26-052176.md) | [(4.9)](/filings/0001628280-25-051372.md) | [19.8 d](/filings/0001628280-26-016661.md) | [5.7](/filings/0001628280-26-032985.md) | [(4.4)](/filings/0001628280-26-052176.md) |
| Diluted EPS | $ per share | [(0.98)](/filings/0001628280-24-045451.md) | not reported | [(0.13)](/filings/0001628280-25-026057.md) | [(1.61)](/filings/0001628280-25-040169.md) | [(2.05)](/filings/0001628280-25-051372.md) | not reported | [(1.23)](/filings/0001628280-26-032985.md) | [(1.63)](/filings/0001628280-26-052176.md) | [(0.94)](/filings/0001628280-25-051372.md) | not reported | [0.07](/filings/0001628280-26-032985.md) | [(1.41)](/filings/0001628280-26-052176.md) |
| Basic EPS | $ per share | [(0.98)](/filings/0001628280-24-045451.md) | not reported | [(0.13)](/filings/0001628280-25-026057.md) | [(1.61)](/filings/0001628280-25-040169.md) | [(2.05)](/filings/0001628280-25-051372.md) | not reported | [(1.23)](/filings/0001628280-26-032985.md) | [(1.63)](/filings/0001628280-26-052176.md) | [(0.94)](/filings/0001628280-25-051372.md) | not reported | [0.07](/filings/0001628280-26-032985.md) | [(1.41)](/filings/0001628280-26-052176.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.2](/filings/0001628280-24-017691.md) | [21.4](/filings/0001628280-25-015331.md) | [31.2](/filings/0001628280-24-023376.md) | [33.7](/filings/0001628280-24-037035.md) | [25.9](/filings/0001628280-24-045451.md) | [3.5](/filings/0001628280-26-016661.md) | [6.0](/filings/0001628280-25-026057.md) | [3.7](/filings/0001628280-25-040169.md) | [3.4](/filings/0001628280-25-051372.md) | [22.4](/filings/0001628280-26-052176.md) | [22.3](/filings/0001628280-26-032985.md) | [18.0](/filings/0001628280-26-052176.md) |
| Current assets | $m | [95.5](/filings/0001628280-24-045451.md) | [97.6](/filings/0001628280-25-015331.md) | [104](/filings/0001628280-24-023376.md) | [104](/filings/0001628280-24-037035.md) | [89.5](/filings/0001628280-24-045451.md) | [90.4](/filings/0001628280-26-016661.md) | [85.7](/filings/0001628280-25-026057.md) | [87.8](/filings/0001628280-25-040169.md) | [83.1](/filings/0001628280-25-051372.md) | [105](/filings/0001628280-26-052176.md) | [101](/filings/0001628280-26-032985.md) | [98.8](/filings/0001628280-26-052176.md) |
| Total assets | $m | [98.6](/filings/0001628280-24-045451.md) | [101](/filings/0001628280-25-015331.md) | [107](/filings/0001628280-24-023376.md) | [107](/filings/0001628280-24-037035.md) | [92.0](/filings/0001628280-24-045451.md) | [93.2](/filings/0001628280-26-016661.md) | [88.5](/filings/0001628280-25-026057.md) | [90.6](/filings/0001628280-25-040169.md) | [85.9](/filings/0001628280-25-051372.md) | [108](/filings/0001628280-26-052176.md) | [104](/filings/0001628280-26-032985.md) | [102](/filings/0001628280-26-052176.md) |
| Current liabilities | $m | [28.0](/filings/0001628280-24-045451.md) | [42.3](/filings/0001628280-25-015331.md) | [39.2](/filings/0001628280-24-023376.md) | [139](/filings/0001628280-24-037035.md) | [131](/filings/0001628280-24-045451.md) | [139](/filings/0001628280-26-016661.md) | [139](/filings/0001628280-25-026057.md) | [144](/filings/0001628280-25-040169.md) | [144](/filings/0001628280-25-051372.md) | [118](/filings/0001628280-26-052176.md) | [108](/filings/0001628280-26-032985.md) | [110](/filings/0001628280-26-052176.md) |
| Total liabilities | $m | [113](/filings/0001628280-24-045451.md) | [129](/filings/0001628280-25-015331.md) | [134](/filings/0001628280-24-023376.md) | [140](/filings/0001628280-24-037035.md) | [132](/filings/0001628280-24-045451.md) | [140](/filings/0001628280-26-016661.md) | [140](/filings/0001628280-25-026057.md) | [145](/filings/0001628280-25-040169.md) | [144](/filings/0001628280-25-051372.md) | [118](/filings/0001628280-26-052176.md) | [108](/filings/0001628280-26-032985.md) | [110](/filings/0001628280-26-052176.md) |
| Shareholders' equity | $m | [(14.7)](/filings/0001628280-24-045451.md) | [(28.0)](/filings/0001628280-26-016661.md) | [(27.5)](/filings/0001628280-25-040169.md) | [(32.9)](/filings/0001628280-25-051372.md) | [(40.3)](/filings/0001628280-25-051372.md) | [(46.8)](/filings/0001628280-26-052176.md) | [(51.7)](/filings/0001628280-26-052176.md) | [(54.1)](/filings/0001628280-26-052176.md) | [(58.4)](/filings/0001628280-25-051372.md) | [(38.1)](/filings/0001628280-26-052176.md) | [(31.9)](/filings/0001628280-26-052176.md) | [(36.0)](/filings/0001628280-26-052176.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.8 d](/filings/0001628280-24-045451.md) | [(9.7) d](/filings/0001628280-25-015331.md) | [2.0](/filings/0001628280-25-026057.md) | [(0.6) d](/filings/0001628280-25-040169.md) | [(5.4) d](/filings/0001628280-25-051372.md) | [(28.5) d](/filings/0001628280-26-016661.md) | [3.4](/filings/0001628280-26-032985.md) | [(6.6) d](/filings/0001628280-26-052176.md) | [4.0 d](/filings/0001628280-25-051372.md) | [(12.7) d](/filings/0001628280-26-016661.md) | [12.2](/filings/0001628280-26-032985.md) | [(6.1) d](/filings/0001628280-26-052176.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001628280-24-045451.md) | [0.0 d](/filings/0001628280-25-015331.md) | [0.0](/filings/0001628280-25-026057.md) | [0.0 d](/filings/0001628280-25-040169.md) | [0.0 d](/filings/0001628280-25-051372.md) | [0.0 d](/filings/0001628280-26-016661.md) | [0.0](/filings/0001628280-26-032985.md) | [0.0 d](/filings/0001628280-26-052176.md) | [0.0 d](/filings/0001628280-25-051372.md) | [0.0 d](/filings/0001628280-26-016661.md) | [0.0](/filings/0001628280-26-032985.md) | [0.0 d](/filings/0001628280-26-052176.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,936](/filings/0001628280-24-017691.md) | [3,973](/filings/0001628280-24-023376.md) | [4,073](/filings/0001628280-24-037035.md) | [4,130](/filings/0001628280-24-045451.md) | [4,242](/filings/0001628280-25-026057.md) | [4,286](/filings/0001628280-25-040169.md) | [4,341](/filings/0001628280-25-051372.md) | [4,618](/filings/0001628280-26-032985.md) | [4,813](/filings/0001628280-26-052176.md) | [5,278](/filings/0001628280-25-051372.md) | [5,455](/filings/0001628280-26-032985.md) | [5,491](/filings/0001628280-26-052176.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,972,405 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052176.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.